title: IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.
abstract: Staphylococcus aureus is the most common cause of skin and soft tissue infections, and rapidly emerging antibiotic-resistant strains are creating a serious public health concern. If immune-based therapies are to be an alternative to antibiotics, greater understanding is needed of the protective immune response against S. aureus infection in the skin. Although neutrophil recruitment is required for immunity against S. aureus, a role for T cells has been suggested. Here, we used a mouse model of S. aureus cutaneous infection to investigate the contribution of T cells to host defense. We found that mice deficient in gammadelta but not alphabeta T cells had substantially larger skin lesions with higher bacterial counts and impaired neutrophil recruitment compared with WT mice. This neutrophil recruitment was dependent upon epidermal Vgamma5+ gammadelta T cell production of IL-17, but not IL-21 and IL-22. Furthermore, IL-17 induction required IL-1, TLR2, and IL-23 and was critical for host defense, since IL-17R-deficient mice had a phenotype similar to that of gammadelta T cell-deficient mice. Importantly, gammadelta T cell-deficient mice inoculated with S. aureus and treated with a single dose of recombinant IL-17 had lesion sizes and bacterial counts resembling those of WT mice, demonstrating that IL-17 could restore the impaired immunity in these mice. Our study defines what we believe to be a novel role for IL-17-producing epidermal gammadelta T cells in innate immunity against S. aureus cutaneous infection.
authors.affiliation: Division of Dermatology, UCLA, Los Angeles, California 90095, USA.
authors.forename: John S
authors.initials: JS
authors.lastname: Cho
authors.forename: Eric M
authors.initials: EM
authors.lastname: Pietras
authors.forename: Nairy C
authors.initials: NC
authors.lastname: Garcia
authors.forename: Romela Irene
authors.initials: RI
authors.lastname: Ramos
authors.forename: David M
authors.initials: DM
authors.lastname: Farzam
authors.forename: Holly R
authors.initials: HR
authors.lastname: Monroe
authors.forename: Julie E
authors.initials: JE
authors.lastname: Magorien
authors.forename: Andrew
authors.initials: A
authors.lastname: Blauvelt
authors.forename: Jay K
authors.initials: JK
authors.lastname: Kolls
authors.forename: Ambrose L
authors.initials: AL
authors.lastname: Cheung
authors.forename: Genhong
authors.initials: G
authors.lastname: Cheng
authors.forename: Robert L
authors.initials: RL
authors.lastname: Modlin
authors.forename: Lloyd S
authors.initials: LS
authors.lastname: Miller
mesh_terms: D000818:Animals; D007371:Interferon-gamma / Q000378:metabolism; D020381:Interleukin-17 / Q000378:metabolism / Q000502:physiology*; D007378:Interleukins / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D009504:Neutrophils / Q000378:metabolism; D012867:Skin / Q000382:microbiology*; D013207:Staphylococcal Skin Infections / Q000276:immunology*; D013211:Staphylococcus aureus / Q000378:metabolism*; D013234:Stem Cells; D013601:T-Lymphocytes / Q000276:immunology; D000097043:Interleukin-22; D000098546:Interleukin-21
chemical_list: D007371:Interferon-gamma; D020381:Interleukin-17; D007378:Interleukins; D000097043:Interleukin-22; D000098546:Interleukin-21